Skip to search formSkip to main contentSkip to account menu

CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine

Known as: CD-133 Dendritic Cell Vaccine, CD133 DC Vaccine 
A cell-based cancer vaccine comprised of autologous dendritic cells (DCs) pulsed with human leukocyte antigen (HLA)-A2-restricted peptides derived… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundCell therapy with bone marrow (BM)-derived progenitors has emerged as a promising therapeutic for refractory angina (RA… 
2018
2018
  • 2018
  • Corpus ID: 73718973
كچ ي هد فده و هقباس : ي ك ي هار زا اه ي ارف لرتنك ي دن نوخ زاس ي , ظنت ي م ب ه سو ي هل MicroRNA… 
2017
2017
In this work we have studied several homologous human genes related to genes involved in neural asymmetric cell division in… 
2010
2010
CD133, a five-transmembrane molecule, has been found on many types of cancers and determined to be a cancer stem cell biomarker…